Effects of Urban Afforestation Activity on Mood, Stress, and Anxiety

Sponsor
Universidad de Granada (Other)
Overall Status
Completed
CT.gov ID
NCT05384301
Collaborator
(none)
154
1
1
11
426.1

Study Details

Study Description

Brief Summary

This single-group pretest-posttest clinical trial aims to evaluate the effects of a single-session afforestation activity on mood, stress, and anxiety in a sample of adults.

Condition or Disease Intervention/Treatment Phase
  • Other: Urban Afforestation Program
N/A

Detailed Description

The participants will perform an afforestation activity for a single session of 90 minutes. The therapist will direct the participants' attention to the visual, auditory, olfactory, and tactile features of the surrounding environment.

Study Design

Study Type:
Interventional
Actual Enrollment :
154 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effects of an Urban Afforestation Activity on Mood, Stress, and Anxiety of Adults
Actual Study Start Date :
May 25, 2022
Actual Primary Completion Date :
Jun 5, 2022
Actual Study Completion Date :
Jun 5, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Urban Afforestation Group

Participants will perform an afforestation activity with a duration of 90 minutes.

Other: Urban Afforestation Program
An afforestation program based on land cultivation and transplantation of several plants for 90 minutes will be implemented.
Other Names:
  • Nature-based activity
  • Afforestation activity
  • Outcome Measures

    Primary Outcome Measures

    1. Mood [Change from baseline the total mood disturbance after 90 minutes.]

      The Spanish adaptation of the 30-item Short Form of the Profile of Mood States will be utilised. There are five questions situated under each mood factor of Anger, Fatigue, Vigour, Friendliness, Tension, and Depressed Mood, which will be rated on a five-point scale starting from 0 indicating "not at all" up to 4 indicating "a lot" to evaluate the current feelings. Higher scores on the vigour and friendliness subscale indicate more positive mood, and higher scores on the remaining subscales indicate more negative mood.

    Secondary Outcome Measures

    1. State stress [Change from baseline state stress after 90 minutes.]

      The perceived stress will be assessed by the 100-mm Visual Analogue Scale, where endpoints are labelled as "None" and "As bad as it could be" from left to right. The scale will yield a single quantitative variable regarded as the state stress score, which is measured by the distance between the far-left end and the participant's mark on the line in millimetres. Lower scores indicate less stress at the moment.

    2. State anxiety [Change from baseline state anxiety after 90 minutes.]

      The 100-mm Visual Analogue Scale for state anxiety will be employed. The endpoints of the scale are labelled as "None" and "As bad as it could be" from left to right. The distance in millimetres between the far-left end and the participant's mark will be regarded as the state anxiety score. Lower scores indicate less anxiety at the moment.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Adults between 18 and 65 years.

    • Any sex and gender.

    Exclusion Criteria:
    • Intake of any psychotropic medication.

    • Other severe or medically unstable diseases that may interfere with participation.

    • Severe cognitive impairment (Mini-Mental State Examination score < 17 out of 30 points).

    • Severe mental disorders in the acute phase or symptomatic phase.

    • Severe intellectual disability.

    • Behavioural alterations as this may interfere with their participation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Granada, Faculty of Health Sciences Granada Andalusia Spain 18071

    Sponsors and Collaborators

    • Universidad de Granada

    Investigators

    • Principal Investigator: José Manuel PÉREZ-MÁRMOL, PhD, Associate Professor

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    José Manuel Pérez Mármol, Associate Professor, Universidad de Granada
    ClinicalTrials.gov Identifier:
    NCT05384301
    Other Study ID Numbers:
    • AfforestMood
    First Posted:
    May 20, 2022
    Last Update Posted:
    Jun 7, 2022
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by José Manuel Pérez Mármol, Associate Professor, Universidad de Granada
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 7, 2022